These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics. Hermans JJ, Thijssen HH. Br J Pharmacol; 1993 Sep; 110(1):482-90. PubMed ID: 8220911 [Abstract] [Full Text] [Related]
3. Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes. Nomura A, Sakurai E, Hikichi N. J Pharm Pharmacol; 1997 Mar; 49(3):257-62. PubMed ID: 9231341 [Abstract] [Full Text] [Related]
12. 1-Hydroxy- and 2-hydroxy-3-methylcholanthrene: regioselective and stereoselective formations in the metabolism of 3-methylcholanthrene and enantioselective disposition in rat liver microsomes. Shou M, Yang SK. Carcinogenesis; 1990 Jun; 11(6):933-40. PubMed ID: 2347067 [Abstract] [Full Text] [Related]
13. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes. Thijssen HH, Flinois JP, Beaune PH. Drug Metab Dispos; 2000 Nov; 28(11):1284-90. PubMed ID: 11038154 [Abstract] [Full Text] [Related]
14. Hepatic microsomal warfarin metabolism in warfarin-resistant and susceptible mouse strains: influence of pretreatment with cytochrome P-450 inducers. Sutcliffe FA, MacNicoll AD, Gibson GG. Chem Biol Interact; 1990 Nov; 75(2):171-84. PubMed ID: 2369784 [Abstract] [Full Text] [Related]